Prevention in Hepatology

Ana-Maria Muñoz-Restrepo,Maria-Cristina Navas,Jimmy Daza,Marcos Girala,Ezequiel Ridruejo,Guido Gerken,Andreas Teufel

DOI: https://doi.org/10.3390/jpm14020132

IF: 3.5083

2024-01-23

Journal of Personalized Medicine

Abstract:The prevention of liver disease has improved significantly in the last few decades, to the point that it can now be considered a true success story. The wide variety of interventions, including comprehensive vaccination strategies, novel medications, lifestyle changes, and even preventive surgeries, have reduced the morbidity and mortality of chronic liver diseases. However, the prevalence of chronic liver diseases is increasing worldwide. Currently, fatty liver disease alone is estimated to be present in as much as 30% of the adult population. Furthermore, there is a trend towards increasing incidences of chronic hepatitis B, and a global lack of success in efforts to eliminate chronic hepatitis C. Thus, improving and efficiently rolling out existing and successful prevention strategies for chronic liver diseases will play an essential role in healthcare throughout the upcoming decades. In this review, we summarize the current options and concepts for preventing chronic liver diseases, highlight their limitations, and provide an outlook on probable future developments to improve awareness, integrated care, and the analysis of big data.

medicine, general & internal,health care sciences & services

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the prevention of chronic liver disease (CLD). Although in the past few decades, through a variety of interventions such as comprehensive vaccination strategies, new drugs, lifestyle changes and even preventive surgeries, the incidence and mortality of chronic liver disease have been significantly reduced, the prevalence of chronic liver disease is still on the rise globally. In particular, the prevalence of non - alcoholic steatohepatitis (NASH) is estimated to be as high as 30% of the adult population. Meanwhile, the incidence of chronic hepatitis B (CHB) is also on the rise, and the world has not yet achieved success in eliminating chronic hepatitis C (CHC). Therefore, the paper emphasizes the importance of improving the application efficiency of existing effective prevention strategies and explores possible future development directions to improve the understanding of chronic liver disease, the level of comprehensive care and the ability of big - data analysis. By summarizing current prevention options and concepts, the paper points out their limitations and looks forward to future development directions, aiming to reduce the occurrence of chronic liver disease and its complications. From both medical and economic perspectives, it will not only benefit patients but also the whole society.